New hope for Drug-Resistant leukemia? experimental pill K0706 tested

NCT ID NCT02629692

NEW Terminated Disease control Sponsor: Sun Pharma Advanced Research Company Limited Source: ClinicalTrials.gov ↗

First seen May 16, 2026 · Last updated May 16, 2026

Summary

This study tested an experimental drug called K0706 in people with chronic myeloid leukemia (CML) or a related blood cancer whose disease no longer responded to at least three other treatments. The goal was to see if the drug was safe and could shrink or control the cancer. The trial was stopped early, so results are limited.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Locations

Azienda Ospedaliera Universitaria Policlinico Umberto I - Università di Roma La Sapienza

Roma, 00161, Italy
Azienda Socio Sanitaria Territoriale di Monza (Presidio San Gerardo)

Monza, Milano, 20900, Italy
Baylor University Medical Center

Dallas, Texas, 75226, United States
Board of Regents of the University System of Georgia

Augusta, Georgia, 30912, United States
Centre Hospitalier Lyon Sud

Pierre-Bénite, Rhone, 69495, France
Centre Léon Bérard

Lyon, Rhone, 69373, France
Cliniques Universitaires Saint-Luc

Brussels, 1200, Belgium
Debreceni Egyetem

Debrecen, 4032, Hungary
Fondazione IRCCS CA' Granda Ospedale Maggiore Policlinico

Milan, 20122, Italy
Hammersmith Hospital

London, Greater London, W120HS, United Kingdom
Hospital Universitari Vall d'Hebron

Barcelona, 08035, Spain
Hospital Universitario 12 de Octubre

Madrid, 28041, Spain
Hospital Universitario La Paz

Madrid, 28046, Spain
Hospital Universitario Ramon y Cajal

Madrid, 28034, Spain
Huntsman Cancer Institute University of Utah

Salt Lake City, Utah, 84112, United States
ICO Badalona - Hospital Universitari Germans Trias i Pujol

Badalona, Barcelona, 08916, Spain
Institut Paoli Calmettes

Marseille, Bouches-du-Rhône, 13273, France
Institutul Oncologic "Prof. Dr. Ion Chiricuta" Cluj-Napoca

Cluj-Napoca, 400124, Romania
Istituto Scientifico Romagnolo Per Lo Studio e La Cura Dei Tumori

Meldola, Forli - Cesena, 47014, Italy
King's College Hospital

London, Greater London, SE5 9NU, United Kingdom
MD Anderson Cancer Center

Houston, Texas, 77030, United States
Mayo Clinic

Jacksonville, Florida, 32224, United States
Meenakshi Mission Hospital & Research Centre

Madurai, Tamil Nadu, 625107, India
Memorial Sloan Kettering Cancer Center - MAIN

New York, New York, 10065, United States
Ospedale Sant'Eugenio

Roma, 00144, Italy
Prince Aly Khan Hospital

Mumbai, Maharashtra, 400010, India
Sahyadri Specialty Hospital

Pune, Maharashtra, 411004, India
Spitalul Clinic Colentina

Bucharest, 020125, Romania
Spitalul Clinic Municipal Filantropia Craiova

Craiova, 200143, Romania
Tata Medical Centre

Kolkata, West Bengal, 700156, India
Tata Memorial Hospital

Mumbai, Maharashtra, 400012, India
The Catholic University of Korea, Seoul St. Mary's Hospital

Seoul, Gyeonggi-do, 6591, South Korea
The Oncology Institute of Hope and Innovation, Innovative Clinical Research Institute

Downey, California, 90241, United States
UCLA Hematologic Malignancy Program

Los Angeles, California, 90024, United States
Uijeongbu Eulji Medical Center, Eulji University

Gyeonggi-do, 11759, South Korea

Conditions

Explore the condition pages connected to this study.

CHRONIC MYELOID LEUKEMIA (FOR PART B AND C) HEALTHY (FOR PART A)